- Home
- NRXP vs CALC Comparison
NRXP vs CALC Comparison
Compare NRXP & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CALC
- Stock Information
- Founded
- NRXP 2015
- CALC 2011
- Country
- NRXP United States
- CALC United States
- Employees
- NRXP N/A
- CALC N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- CALC Health Care
- Exchange
- NRXP Nasdaq
- CALC Nasdaq
- Market Cap
- NRXP 34.7M
- CALC 36.0M
- IPO Year
- NRXP N/A
- CALC N/A
- Fundamental
- Price
- NRXP $2.01
- CALC $1.85
- Analyst Decision
- NRXP Strong Buy
- CALC Strong Buy
- Analyst Count
- NRXP 4
- CALC 3
- Target Price
- NRXP $28.25
- CALC $16.33
- AVG Volume (30 Days)
- NRXP 185.3K
- CALC 63.1K
- Earning Date
- NRXP 05-13-2025
- CALC 05-12-2025
- Dividend Yield
- NRXP N/A
- CALC N/A
- EPS Growth
- NRXP N/A
- CALC N/A
- EPS
- NRXP N/A
- CALC N/A
- Revenue
- NRXP N/A
- CALC N/A
- Revenue This Year
- NRXP N/A
- CALC N/A
- Revenue Next Year
- NRXP N/A
- CALC N/A
- P/E Ratio
- NRXP N/A
- CALC N/A
- Revenue Growth
- NRXP N/A
- CALC N/A
- 52 Week Low
- NRXP $1.10
- CALC $1.81
- 52 Week High
- NRXP $6.01
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- NRXP 42.26
- CALC 36.21
- Support Level
- NRXP $1.95
- CALC $1.81
- Resistance Level
- NRXP $2.12
- CALC $2.10
- Average True Range (ATR)
- NRXP 0.18
- CALC 0.16
- MACD
- NRXP 0.01
- CALC 0.00
- Stochastic Oscillator
- NRXP 23.08
- CALC 10.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.